Cambridge, UK: 12 May 2021
One Nucleus, the non-for-profit Life Science membership group headquartered in Cambridge exists to support growing Life Science businesses throughout their life cycle as they translate great science into better patient outcomes. This includes facilitating connections between companies and expert services that enable members to operate safely, efficiently and with savings against key purchased items. The Group Purchasing Scheme saves members over £3M per annum via negotiated Preferred Supplier Agreements. Circular1 Health, a leading provider of Covid-19 testing to…
Cambridge, 12th May 2021: The Babraham Research Campus’ vision is to be one of the best places in the world for discovery bioscience research and innovation; a leading sustainable ecosystem to start, nurture, scale and grow bioscience business.
Already one of the UK’s leading locations to support world leading discovery research and early-stage bioscience enterprise, the Campus partners (The Babraham Institute, the Biotechnology and Biological Sciences Research Council, and Babraham Bioscience Technologies Ltd) have recently undertaken a strategic review of the Campus and the opportunity for…
Cambridge, UK: 11 May 2021
One Nucleus, the non-for-profit Life Science membership group headquartered in Cambridge exists to support growing Life Science businesses throughout their life cycle as they translate great science into better patient outcomes. This includes facilitating connections between companies and expert development partners. tranScrip, a leading provider of specialist services to support Pharma and biotech companies on product development and life cycle management has become the latest company to join the One Nucleus Partner Programme. The programme is tailor-made to meet…
NOTTINGHAM, UK – 6 May, 2021 – Life Science Newswire – Integrated drug discovery and pre-clinical solutions provider, Sygnature Discovery, has appointed Dr. David Lustig to the role of Vice President Business Development - United States. Dr. Lustig will play a crucial role in the company’s US expansion, following the opening of Sygnature’s second US office at Oyster Point, South San Francisco in April.A significant part of Sygnature’s customer base is already located in North America, ranging from major pharma through to small seed-funded biotechs, based all across the US and over the border…
Cambridge 10th May 2021: Accelerate@Babraham, the bio-entrepreneurial incubator initiative founded and developed by the Babraham Research Campus - supported by key industry and investor organisations - opens applications for its 2021/22 cohort today.The five-month programme, created out of a desire to support and nurture early-stage life science ventures attempting to navigate this fast-moving sector, offers up to five innovative entrepreneurs the opportunity to experience life as part of one of the most successful locations for life science start-ups in Europe.The programme, starting…
Reading Scientific Services Ltd (RSSL) has been named Employer of the Year 2021 at the Thames Valley Awards, in recognition of its outstanding dedication to staff development, engagement and wellbeing.
RSSL successfully demonstrated its commitment to employees through a diverse, inclusive and creative programme of initiatives. Importantly, the organisation also showed its ability to adapt to the restrictions and pressures placed on staff during the pandemic; moving key aspects online and boosting other areas of support where they were needed most.
Commenting on the win, Jacinta George,…
Reading Scientific Services Ltd (RSSL) has been named Business of the Year 2021 at the Thames Valley Awards, with the judges praising its forward-thinking approach and strong commercial performance.
“We are delighted to receive this award, especially given the huge challenges of the last year. I am so proud of everyone at RSSL for continuing to deliver an exceptional level of service for our clients, while still supporting each other. This resilience, determination and strong sense of purpose has been instrumental in helping our business grow and emerge stronger than ever before,” said…
Research Triangle Park, NC, USA and Cambridge, UK, 5 May 2021 -- Inivata, a leader in liquid biopsy, today announces that NeoGenomics, Inc (NASDAQ: NEO.), a leading provider of cancer-focused genetic testing services and global oncology contract research services, has agreed to acquire Inivata. The acquisition follows a $25 million minority equity investment by NeoGenomics in Inivata in May 2020, at which time NeoGenomics was granted a fixed price option to purchase the remainder of Inivata for $390 million.
Inivata, with its leading liquid biopsy technology platform, will remain a…
Cambridge, UK, 04 May 2021: Mogrify Limited (Mogrify®), a biopharmaceutical company aiming to transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies, announced today the second closing of its Series A financing of $17 million USD, bringing the total raised to $33 million USD in this round. The funding will support the advancement of Mogrify’s immuno-oncology and ophthalmology programs, as well as continued platform development and the exploration of cell reprogramming for novel therapeutic application.
This second close of the Company’s…